Alternatives to Selitectix

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Life science company pioneering drug discovery with AI and advanced technologies.

AI platform for computational biologists to accelerate drug discovery and therapeutic development.

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for designing novel molecular structures for new medicines.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Clinical-stage precision medicine company using protein motion insights for drug discovery.